Apollon Formularies - Kevin Sheil

Kevin Sheil

A capital markets veteran with over 30 years’ experience, Mr Sheil contributes a broad depth of experience and knowledge of capital markets to the board of Apollon. Kevin also brings key expertise to Apollon UK from working as a consultant to an Artificial Intelligence (“AI”) technology firm, providing valuable input as Apollon continues to grow its line of AI-determined patient specific cannabis medicines and commercialise its unique 3D Pharmaceutical Printer. Mr. Sheil began his career at the London Stock Exchange before moving into corporate broking with HSBC, Credit Lyonnais and Barclays.

Mr. Sheil was a telecom sector specialist with Barclays, Credit Suisse and then Citibank where he worked for over 10 years and was consistently top ranked in Extel & Institutional Investor surveys. Mr Sheil worked as Head of Multi-Product Sales at Citibank and was responsible for broking all equity-based products. Mr Sheil has also spent over nine years as a general equity fund manager for Trium Capital Managers.

Schedule Appointment

Schedule an appointment with us to discuss either:
Physician Consultation, Share Dealing Enquiries, General Enquiries or legal wholesale purchase of Apollon Products